This is similar to the high rate of PIK3CA mutations in HPV(+) cervical cancer (39–41% cases; TCGA; www.cbioportal.org), implicating the biological importance of PI3K activation in these HPV-positive cancers. The gene discussed is PIK3CB; the disease is cervical cancer.